Diabetes mellitus is 1one of the most common chronic diseases in the world, with an
estimated worldwide prevalence of over 176 million in 2000. Furthermore, the prevalence of …

Background Steroid‐sparing strategies have been attempted in recent decades to avoid
morbidity from long‐term steroid intake among kidney transplant recipients. Previous …

New onset diabetes mellitus (NODM) is a serious complication of transplantation. This meta-
analysis evaluates the reported incidence of NODM after solid organ transplantation in …

Although renal transplantation ameliorates cardiovascular risk factors by restoring renal
function, it introduces new cardiovascular risks including impaired glucose tolerance or …

New onset hyperglycemia and diabetes are associated with increased cardiovascular risk
after kidney transplantation. Background Post-transplant diabetes (PTDM) is a common and …

The impact of early-diagnosed new-onset post-transplantation diabetes mellitus (PTDM) on
cardiovascular (CV) disease is not well described. The objectives of the present prospective …

Aims/hypothesis The human cytomegalovirus (CMV) may increase the risk of diabetes
mellitus, but the literature is scarce. The present study was designed to test the hypothesis …

Current immunosuppressive regimens in renal transplantation typically include calcineurin
inhibitors (CNIs) and corticosteroids, both of which have toxicities that can impair recipient …

Background. Cardiovascular disease, the most common cause of death with a functioning
graft among kidney transplant recipients, can be exacerbated by immunosuppressive drugs …

Cardiovascular disease is a prevalent and serious complication after solid organ
transplantation. Treatment with glucocorticoids is associated with increased risk for diabetes …